Latest Market News

Page 531 of 1569
Ovanti Limited has secured $8 million through a strategic share placement to accelerate its US Buy Now, Pay Later expansion, highlighted by a new three-year NASCAR sponsorship deal.
Victor Sage
Victor Sage
8 Oct 2025
IODM Limited reports a striking 179% revenue surge in its UK Education segment for September 2025, driving a 210% year-to-date increase and prompting an upward revision of first-quarter group cash receipts.
Sophie Babbage
Sophie Babbage
8 Oct 2025
Alligator Energy has begun construction of its Samphire Project Field Recovery Trial near Whyalla, marking a key step towards uranium production amid a strengthening market.
Maxwell Dee
Maxwell Dee
8 Oct 2025
Immuron Limited has taken a significant step forward by submitting an Investigational New Drug application to the FDA for IMM-529, targeting Clostridioides difficile infection. The company aims to start Phase 2 trials in early 2026, addressing a critical unmet need in infectious disease treatment.
Ada Torres
Ada Torres
8 Oct 2025
Eastern Metals Limited (ASX – EMS) announces a significant return of capital through an in specie distribution of Australian Gold and Copper Ltd shares, pending shareholder approval and key conditions.
Maxwell Dee
Maxwell Dee
8 Oct 2025
Eastern Metals Limited has announced a 2-for-1 consolidation of its ordinary shares and options, set to reshape its capital structure with trading on a deferred settlement basis starting mid-November 2025.
Maxwell Dee
Maxwell Dee
8 Oct 2025
Eastern Metals Limited has entered a definitive agreement to acquire Raptor Resources Limited, adding significant copper and gold assets in Canada and Western Australia, alongside a planned capital raise to fund exploration and ASX reinstatement.
Maxwell Dee
Maxwell Dee
8 Oct 2025
Transurban Group reported a 2.7% rise in average daily traffic across its portfolio in the September quarter 2025, with growth in all key markets supporting a reaffirmed FY26 distribution forecast.
Nora Hopper
Nora Hopper
8 Oct 2025
Dimerix’s latest PARASOL collaboration analysis reinforces proteinuria as a pivotal endpoint in their Phase 3 FSGS trial, setting the stage for FDA discussions on accelerated approval pathways.
Ada Torres
Ada Torres
8 Oct 2025
Redox Limited reported a 9.4% increase in sales revenue for FY25 despite challenging global conditions, while declaring a robust dividend payout that exceeds its policy. The company’s strategic focus on specialty chemicals, operational expansion, and ESG commitments positions it well for continued growth.
Victor Sage
Victor Sage
8 Oct 2025
Transurban's September quarter update reveals steady traffic growth across all key markets, underpinning a reaffirmed 6% increase in FY26 distributions.
Nora Hopper
Nora Hopper
8 Oct 2025
Airtasker has landed a £2.5 million media investment from Channel 4’s venture arm to accelerate growth in the UK, building on a strong marketplace performance and deepening a strategic media partnership.
Sophie Babbage
Sophie Babbage
8 Oct 2025